Therapicon® is a biochemotechnology company that develops also medicines designed to yield better therapeutic outcomes and improve patients' compliance and lives. Our products, which use novel molecules and innovative drug technologies, has target widespread common and serious diseases, including osteoporosis, immunological disorders, peripheral circulatory disorders and oromucosal inflammation conditions. These products are designed according to patients needs and compliance, with the goal of ensuring that patients consistently take their daily medications for long-term treatment success.
Therapicon® partners with leading pharmaceutical companies and also creates independent proprietary products to fill the clinical demand and the market opportunities, building a wide range of capabilities, including innovative research programs, clinical development, industrial scale manufacturing projects and a commercial partnerships in the marketplace.
Some of our proprietary products are listed hereby:
Therapicon® is a registered trade-mark in Italy and at OMPI (WIPO)-Geneva